Background This overview of systematic reviews with meta-analysis summarized the
prevalence of anxiety and depression in different types of tumors around the world. Methods …

Simple Summary Targeted agents, such as Bruton's Tyrosine Kinase inhibitors and BCL-2
inhibitors, have transformed the treatment landscape for Chronic Lymphocytic Leukemia …

Very little is known about the impact of living with non-muscle invasive bladder cancer
(NMIBC). NMIBC patients' experiences of their illness–in terms of their perceptions, coping …

Objective. Research reporting the unmet needs of individuals with haematological cancers
under watch‐and‐wait is scarce, despite reports of elevated levels of psychological distress …

Patients with hematologic disorders may experience anxiety and depression due to their
immunocompromised status and potential side effects of therapies. Healthy lifestyle …

Introduction There is an historical initiative to establish common theoretical ground to
support a framework for assessing health-related quality of life (HRQL). Our aim was to add …

Chronic diseases are the leading cause of mortality, morbidity and disability and its
prevalence continues to increase. Chronic disease can impact every dimension of a …

OBJECTIVES: The objectives of the PREFERENCE Study are to characterize preferences of
MGUS and SMM patients for early intervention according to attributes of the intervention …

The introduction of highly effective and less toxic therapies has led to a significant reduction
in CLL-related mortality. US SEER data show that patients diagnosed in 2015 had a 5-year …

Patients with hematologic disorders may experience anxiety and depression due to their
immunocompromised status and potential side effects of therapies. Healthy lifestyle …